|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2022
vol. 124 abstract:
Review paper
Focal therapies for retinoblastoma
Krzysztof Cieślik
1
,
Anna Rogowska
1
,
Wojciech Hautz
1
KLINIKA OCZNA 2022, 124, 3:131-136
Online publish date: 2022/03/31
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Currently, the primary treatment for retinoblastoma is intravenous and/or intraarterial chemotherapy. However, adjuvant focal therapies are also an essential component in the treatment of this cancer. The article discusses the methods of focal treatment of retinoblastoma: cryotherapy, transpupillary laser thermotherapy, transpupillary laser thermotherapy with intravenous indocyanine, brachytherapy, enucleation, and intraarterial and bicameral injections of melphalan. Particular attention is given to the latest methods of treatment including topical chemotherapy (intravitreal injections) and intraarterial chemotherapy. These modern topical treatments help salvage the eye in an increasing number of patients with advanced retinoblastoma.
keywords:
retinoblastoma, thermotherapy, cryotherapy, melphalan, brachytherapy |
|
POLSKI
